Skip to content

Wound Catheter Vs LA Bolus in Renal Transplant: RCT

Wound Catheter Vs LA Bolus in Renal Transplant: RCT

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06011421
Enrollment
88
Registered
2023-08-25
Start date
2022-01-31
Completion date
2023-11-01
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound

Brief summary

Pain control is an important part of patients' care after a kidney transplant. Currently patients receive a one off injection of Local Anaesthetic (LA) in the wound at the end of the operation followed by Intravenous morphine through a Patient Controlled Analgesia System (PCAS), a button pressed to provide a calculated dose with lock out times for safety. Through this study the aim to test the efficiency of Continuous Local Anaesthetic Infiltration via Wound Catheter (LAWC) which is a method to deliver Local Anaesthetic over a longer period of time after the operation. LAWC are currently in use in a variety of surgical specialities including Liver surgery. Patients participating in this study will be allocated randomly to one of 2 groups; one will receive LA at the end of the operation as per current practice and one will receive LAWC. It then compare outcomes such as the the dose of morphine required in the PCAS, quality of pain control and improvement in recovery.

Interventions

DEVICELocal Anaesthetic Wound Catheter Insertion

Use of the Local Anaesthetic Wound Catheter Insertion during kidney transplant

Sponsors

The Leeds Teaching Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* Primary kidney transplantation * Single kidney transplantation * Signed informed Consent

Exclusion criteria

* Midline laparotomy * Dual kidney transplantation * Kidney re-transplantation * Multi-organ transplantation * Patients on Long term opiates * Patients with psychiatric illness

Design outcomes

Primary

MeasureTime frameDescription
Total Dose of IV Morphine in the first 24 hours post op24 hoursMeasurment of the dose delivered in 24 hours

Countries

United Kingdom

Contacts

Primary ContactSonsoles Martinez-Lopez
sonsoles.martinez-lopez@nhs.net0113 243 3144

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026